BamSEC and AlphaSense Join Forces
Learn More

Immunic Inc.

NASDAQ: IMUX    
Share price (12/27/24): $1.03    
Market cap (12/27/24): $92.8 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from S-8 15 pages Immunic, Inc. Amended and Restated 2021 Employee Stock Purchase Plan
12/34/56
EX-4.3
from S-8 29 pages Immunic, Inc. 2019 Omnibus Equity Incentive Plan, as Amended on June 28, 2023 and March 4, 2024
12/34/56
EX-4.3
from 10-K 3 pages Description of Capital Stock
12/34/56
EX-4.1
from 8-K 17 pages Pre-Funded Warrant to Purchase Common Stock Immunic, Inc
12/34/56
EX-4.1
from S-3 37 pages Immunic, Inc. Issuer and as Trustee Indenture Dated as of [ ] Debt Securities
12/34/56
EX-4.2
from S-8 29 pages Immunic, Inc. 2019 Omnibus Equity Incentive Plan, as Amended
12/34/56
EX-4.2
from 10-K 3 pages Description of Capital Stock
12/34/56
EX-4.2
from 10-Q 3 pages Description of Capital Stock
12/34/56
EX-4.1
from 8-K 19 pages Immunic, Inc. Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 10-Q 3 pages Description of Capital Stock
12/34/56
EX-4.2
from 10-Q 3 pages Description of Capital Stock
12/34/56
EX-4.2
from 10-K 3 pages Description of Capital Stock
12/34/56
EX-4.2
from 10-Q 3 pages Description of Capital Stock
12/34/56
EX-4.2
from 10-Q 3 pages Description of Capital Stock
12/34/56
EX-4.3
from S-8 15 pages Immunic, Inc. Amended and Restated 2021 Employee Stock Purchase Plan
12/34/56
EX-4.2
from 10-Q 3 pages Description of Capital Stock
12/34/56
EX-4.2
from 10-K 3 pages Description of Capital Stock
12/34/56
EX-4.1
from S-3 38 pages Immunic, Inc. Issuer and as Trustee Indenture Dated as of , 20 Debt Securities
12/34/56
EX-4.2
from S-8 30 pages Immunic, Inc. 2019 Omnibus Equity Incentive Plan
12/34/56
EX-4.3
from S-8 8 pages Vital Therapies, Inc. Amended & Restated 2017 Inducement Equity Incentive Plan Stock Option Agreement
12/34/56